Understanding how a specific immune response is activated in human immune cells
A novel mechanism for NLRP3 inflammasome activation in human macrophages
This study is looking at how a part of your immune system called the NLRP3 inflammasome works when your body faces infections or stress, with the hope of finding new ways to treat inflammatory diseases that can happen when this system goes into overdrive.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11093385 on NIH RePORTER |
What this research studies
This research investigates the NLRP3 inflammasome, a critical component of the immune system, particularly in human macrophages. It aims to uncover the molecular mechanisms that trigger its activation in response to infections and cellular stress. By studying how this process works in humans, the research seeks to differentiate human responses from those observed in animal models, which often lack certain human-specific components. The ultimate goal is to identify potential new treatment strategies for inflammatory diseases linked to excessive inflammasome activation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from inflammatory diseases, particularly those related to Alzheimer's disease and other conditions linked to NLRP3 inflammasome activation.
Not a fit: Patients with non-inflammatory conditions or those not affected by Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel therapies for inflammatory diseases, improving patient outcomes.
How similar studies have performed: Previous research has shown that targeting inflammasome pathways can lead to significant advancements in treating inflammatory diseases, indicating a promising avenue for this approach.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Stehlik, Christian — Cedars-Sinai Medical Center
- Study coordinator: Stehlik, Christian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.